Another direction of research is the use of gene therapy to increase the expression of chemokines that induce the infiltration of a tumor by anticancer TILs—for example, CXCR3 ligands such as CXCL10 [331,332,333] and CXCL11 [334]. Here, CXCR3 is linked to neoplasm.